AAN publishes guidelines for Betaseron

Facing mounting confusion and rumors predicting that the American Academy of Neurology would endorse expanded clinical use of Chiron Corp.'s Betaseron multiple sclerosis treatment, the AAN late

Read the full 271 word article

How to gain access

Continue reading with a
two-week free trial.